The Booming North Africa Non-Invasive Prenatal Testing Market Is In Trends By Increased Awareness About Early Detection Of Genetic Disorders
North Africa Non-Invasive Prenatal Testing (NIPT) market comprises Non-Invasive tests such as DNA sequencing and proteomics that analyze cell-free DNA circulating in a pregnant woman's blood. NIPT screens for genetic abnormalities such as trisomy 21, trisomy 18, trisomy 13 and detect fetal sex of the baby. The tests analyze cffDNA from the placenta that enters maternal blood to provide early risk assessments for fetal aneuploidies as early as 9-10 weeks of gestation.
The Global North Africa Non-Invasive Prenatal Testing Market is estimated to be valued at US$ 3805.83 Bn in 2024 and is expected to exhibit a CAGR of 6.9% over the forecast period 2024 To 2031.
Key Takeaways
Key players operating in the North Africa Non-Invasive Prenatal Testing Market Growth are Enraf-Nonius B.V., DJO Global, EMS Physio Ltd., Dynatronics Corporation. These companies are investing significantly in development of advanced tools and techniques to expand the adoption of NIPT.
The growing demand for early detection of fetal abnormalities is a major factor driving growth of the market. Rising awareness about advantages of NIPT over traditional invasive prenatal diagnosis has increased adoption of NIPT. Additionally, increasing maternal age and rising prevalence of genetic disorders have further fueled adoption of NIPT.
Geographical expansion across regions has also boosted market revenues. Major players are focusing on offering affordable NIPT solutions to emerging economies of North Africa to capitalize on high growth opportunities.
Market key trends
The key trend gaining momentum in the North Africa Non-Invasive Prenatal Testing market is the development of new tests for detection of additional chromosomal microdeletion and microduplication syndromes. Players are developing advanced NIPT tools that analyze a larger portion of the fetal genome and facilitate screening for additional disorders. This expands clinical applications of NIPT and drives its adoption. Additionally, the use of artificial intelligence and machine learning technologies to improve accuracy of NIPTS is also a major trend witnessed in the market.
Porter’s Analysis
Threat of new entrants: The threat is moderate as non-invasive prenatal testing industry require large capital investments in research and development. However, technology development can reduce barriers.
Bargaining power of buyers: The power is moderate to high as buyers have a large number of options to choose from and can demand price reductions.
Bargaining power of suppliers: The power is low as there are many suppliers for inputs and suppliers do not have control over pricing.
Threat of new substitutes: The threat is high as new non-invasive technologies are continuously emerging as substitutes.
Competitive rivalry: The rivalry is high amongst existing players to expand market share and gain competitive advantage.
Geographically, the market in Egypt accounted for the largest share in terms of value in North Africa non-invasive prenatal testing market. The large population and rising awareness about prenatal screening are major factors driving the market in Egypt.
Algeria is expected to witness the fastest growth during the forecast period. Increasing focus of government on improving healthcare infrastructure and availability of quality testing is expected to boost the adoption of non-invasive prenatal tests in the country. Rising disposable incomes are also facilitating the growth of the market.
Get More Insights On This Topic: North Africa Non-Invasive Prenatal Testing Market
English
Arabic
Français
Español
Português
Deutsch
Dutch
Italiano
Russian
Romaian